Substandard and falsified medical products may cause harm to patients Ruby Khatun Khatun4 April 2018 10:15 AM ISTKolkata: Substandard and falsified medical products may cause harm to patients and fail to treat the diseases for which they were intended.Falsified...
East Bridge Capital buys 3.86 percent additional stake in Fortis for Rs 256 crore Ruby Khatun Khatun4 April 2018 10:10 AM ISTNew Delhi: East Bridge Capital Master Fund has bought an additional 3.86 percent stake in Fortis Healthcare for over Rs 256 crore through a market...
European Medicines Agency to review Sanofi-Regeneron's Dupixent, Cemiplimab Ruby Khatun Khatun4 April 2018 9:45 AM ISTPARIS: The European Medicines Agency (EMA) will review the Dupixent (dupilumab) and Cemiplimab products being developed by drugmakers Sanofi and...
Allergan weighs options for women's health unit: Report Ruby Khatun Khatun4 April 2018 9:30 AM ISTAllergan Plc, which has been looking for ways to counter its stock slump as new threats to its top-selling skin and eye drugs have emerged, is...
BIG DEAL: ChrysCapital to buy 10 percent stake in Mankind for Rs 2,280 crore Ruby Khatun Khatun3 April 2018 3:36 PM ISTMumbai: In what can be termed as the largest private equity deal in Indian healthcare industry till date -Mankind Pharma has agreed to sell its 10...
Strides Shasun gets USFDA approval for generic Ibuprofen capsules Ruby Khatun Khatun3 April 2018 10:30 AM ISTNew Delhi: Drug firm Strides Shasun said it has received approval from the US health regulator for generic Ibuprofen capsules, 200 mg, used for...
Corona Remedies acquires two brands from Abbott Ruby Khatun Khatun3 April 2018 10:18 AM ISTAhmedabad: City-based pharma firm Corona Remedies announced the acquisition of Obimet and Thyrocab brands, comprising of 14 product line extensions,...
Lupin gets Health Canada clearance for Pithampur unit Ruby Khatun Khatun3 April 2018 10:15 AM ISTNew Delhi: Drug firm Lupin Ltd said its Pithampur unit 2 manufacturing facility located in Indore has been cleared by Health Canada after a...
Prices of 869 formulations to go up by 3.44 percent: NPPA Ruby Khatun Khatun3 April 2018 10:00 AM ISTNew Delhi: Prices of 869 formulations, including antibiotics, cancer and cardiovascular disease treatment drugs and two types of coronary stents, have...
FDA refuses to review Alkermes depression treatment, seeks more trials Ruby Khatun Khatun3 April 2018 9:45 AM ISTAlkermes Plc has been told to conduct more clinical trials of its experimental depression treatment after the U.S. Food and Drug Administration...
Celgene Chief Operating Officer Scott Smith abruptly resigns Ruby Khatun Khatun3 April 2018 9:30 AM ISTCelgene Corp said Chief Operating Officer Scott Smith is leaving the company, effective immediately.The company did not cite a reason for his...
Why mandatory USFDA nod for medical devices, Questions Parliamentary Panel Ruby Khatun Khatun2 April 2018 5:35 PM ISTThe Committee observed that since basic equipment like a multiparameter monitor, defibrillator, transport monitor among many others are easily...
